Medline's IPO Raises $6.3 Billion, Valuation Reaches $35.5 Billion
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 05 2026
0mins
Should l Buy MDLN?
Source: Fool
- IPO Financing Scale: Medline's IPO successfully raised $6.3 billion at a price of $29 per share, significantly enhancing the company's capital structure, with plans to use the proceeds to pay down $16.5 billion in debt, thereby improving financial health.
- Sales Growth Momentum: Since its founding in 1966, Medline has achieved an average annual sales growth of 18%, with projections indicating sales will reach $30 billion by 2026, demonstrating strong growth potential in the medical supply market, particularly given the resilience of healthcare demand amid economic uncertainties.
- Market Competitive Advantage: With 335,000 products and 33 manufacturing facilities, Medline offers next-day delivery to 95% of U.S. customers, leveraging its private label products to enhance margins and solidify its leadership position in the medical product supply chain.
- Superior Financial Performance: Medline boasts a gross margin of approximately 27.4%, significantly higher than key competitors, and is projected to generate $1.5 billion in free cash flow in 2025, showcasing its profitability and cash flow generation capabilities, further enhancing its investment appeal.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MDLN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MDLN
Wall Street analysts forecast MDLN stock price to rise
14 Analyst Rating
13 Buy
1 Hold
0 Sell
Strong Buy
Current: 44.000
Low
42.00
Averages
47.92
High
52.00
Current: 44.000
Low
42.00
Averages
47.92
High
52.00
About MDLN
Medline Inc. is a provider of medical-surgical products and supply chain solutions serving all points of care. The Company delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. It operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Supply Chain Partnership Award: Medline was awarded the HIRC Highest Member Choice Award, recognizing its long-term partnerships with healthcare providers through shared problem-solving and commercial maturity, highlighting its leadership in the industry.
- Resiliency Award Recognition: The company also received the HIRC Distinguished Member Choice Award, indicating its ongoing efforts in operational rigor and contingency readiness, further solidifying its critical role in the healthcare supply chain.
- Transparency Badge Renewal: Medline renewed its HIRC Transparency Badge, demonstrating its commitment to sharing supply chain visibility information, which enhances trust and collaboration with healthcare providers.
- Global Impact: As the largest provider of medical-surgical products, Medline operates in over 100 countries with more than 45,000 employees, continuously driving improvements in clinical, financial, and operational outcomes in the healthcare sector.
See More
- Supply Chain Partnership Award: Medline was awarded the HIRC Highest Member Choice Award, recognizing its long-term partnerships with healthcare providers through shared problem-solving and commercial maturity, highlighting its leadership in the industry.
- Resiliency Award Recognition: Medline also received the HIRC Distinguished Member Choice Award, honoring its ongoing efforts in operational rigor and demand discipline, further solidifying its significance in the healthcare supply chain.
- Transparency Badge Renewal: The company renewed its HIRC Transparency Badge, indicating its commitment to supply chain visibility and resiliency diagnostics, enhancing trust with healthcare providers.
- Strategic Customer Focus: Medline executives emphasized that customer orientation remains central to the company's strategy, with ongoing commitments to resiliency and transparency driving its market-leading supply chain approach.
See More
- New Distribution Center: Medline plans to construct a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expected to be fully operational by Q2 2027, marking the company's first new DC in 2026 and reflecting its ongoing growth trajectory post-IPO.
- Market Expansion Strategy: This distribution center will complement the existing Wilmer location in the Dallas-Fort Worth market, aimed at serving the expanding customer base in the region, thereby strengthening Medline's market position in the healthcare supply chain.
- Technological Investment Upgrade: The new center will incorporate advanced technologies used in Medline's other large distribution centers, including the AutoStore storage and retrieval system, which is expected to enhance operational efficiency and optimize inventory management, improving customer service capabilities.
- Customer Service Commitment: Medline's distribution network enables next-day delivery to 95% of its U.S. customers, and with over 26 million square feet of warehouse space and 80 days of inventory, the company demonstrates a strong commitment to meeting evolving customer needs through continuous investment.
See More
- New Distribution Center: Medline plans to construct a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expected to be fully operational by Q2 2027, marking the company's first new DC in 2026 and reflecting its ongoing growth trajectory post-IPO.
- Network Expansion Strategy: This center will complement the existing Wilmer location in the Dallas-Fort Worth market, aimed at addressing the expanding customer base in the region, thereby enhancing Medline's market position in the healthcare supply chain.
- Technological Innovation: The new facility will incorporate advanced technologies similar to those used in Medline's other large distribution centers, including the AutoStore storage and retrieval system, which is expected to improve operational efficiency and optimize inventory management for faster customer response.
- Enhanced Customer Service: Medline's distribution network enables next-day delivery to 95% of its U.S. customers, showcasing its commitment and capability to meet customer needs, further solidifying its leadership position in the medical product supply chain.
See More
- Successful Secondary Offering: Medline Inc. has completed a secondary offering of 86.25 million shares of Class A common stock at a public price of $41.00 per share, indicating sustained market demand despite the company not participating directly in the sale.
- Key Shareholder Participation: The offering involved selling stockholders affiliated with Blackstone, Carlyle Group, and Hellman & Friedman, suggesting these investors maintain an optimistic outlook on Medline's long-term prospects, potentially boosting market confidence.
- Strong Underwriter Lineup: Top investment banks including Goldman Sachs, Morgan Stanley, and BofA Securities acted as global coordinators, reflecting market recognition of Medline and laying a foundation for future financing activities.
- Compliance Statement: The offering adheres to SEC registration statements, ensuring compliance and reducing legal risks, which further enhances investor trust in Medline.
See More
- Annual Awards Ceremony: Medline awarded its 2025 Distribution Center of the Year and SAFE Awards to top-performing facilities in the U.S., highlighting the company's commitment to operational excellence across safety, service, and quality metrics.
- Award Distribution: Rialto, California, and Katy, Texas, received the Distribution Center of the Year and SAFE Awards respectively, while Richmond, Virginia, achieved the rare distinction of winning both awards, showcasing its outstanding safety and service performance.
- Supply Chain Efficiency: Medline's network of 45 distribution centers enables next-day delivery to 95% of U.S. customers, reflecting the company's effective management of healthcare supply chains and the dedication of its team members.
- Safety Culture Development: The Richmond center's team emphasizes that safety is not just a program but a core part of their culture, ensuring employees work in a safe environment, which enhances overall service quality and employee satisfaction.
See More








